Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 9/20 | 0.79 |
| ▸ | LMNA | P02545 | 9/20 | 0.79 |
| ▸ | MAPT | P10636 | 6/20 | 0.79 |
| ▸ | TSHR | P16473 | 5/20 | 0.79 |
| ▸ | NR3C1 | P04150 | 4/20 | 0.79 |
| ▸ | PGR | P06401 | 4/20 | 0.79 |
| ▸ | AR | P10275 | 4/20 | 0.79 |
| ▸ | NR1I2 | O75469 | 3/20 | 0.79 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.79 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.79 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.79 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.79 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.77 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.71 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.71 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.71 |
| ▸ | SHBG | P04278 | 4/20 | 0.71 |
| ▸ | SERPINA6 | P08185 | 4/20 | 0.71 |
| ▸ | GPBAR1 | Q8TDU6 | 3/20 | 0.71 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4617560 | 1.00 | CYP3A4 (0.79) | CYP3A4LMNAMAPTTSHRNR3C1 | |
| SCHEMBL7996078 | 1.00 | CYP3A4 (0.79) | CYP3A4LMNAMAPTTSHRNR3C1 | |
| SCHEMBL4617563 | 1.00 | CYP3A4 (0.79) | CYP3A4LMNAMAPTTSHRNR3C1 | |
| SCHEMBL2082800 | 1.00 | CYP3A4 (0.79) | CYP3A4LMNAMAPTTSHRNR3C1 | |
| SCHEMBL18438757 | 1.00 | CYP3A4 (0.79) | CYP3A4LMNAMAPTTSHRNR3C1 | |
| SCHEMBL15369348 | 1.00 | CYP3A4 (0.79) | CYP3A4LMNAMAPTTSHRNR3C1 | |
| SCHEMBL2600420 | 1.00 | CYP3A4 (0.79) | CYP3A4LMNAMAPTTSHRNR3C1 | |
| Propionic Acid SCHEMBL26659955 | 0.94 | CYP3A4 (0.80) | CYP3A4LMNAMAPTTSHRNR3C1 | |
| SCHEMBL8814296 | 0.92 | CYP3A4 (0.80) | CYP3A4LMNAMAPTTSHRNR3C1 | |
| Butyric Acid SCHEMBL26659976 | 0.91 | CYP3A4 (0.73) | CYP3A4LMNAMAPTTSHRNR3C1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 494 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122063219-A | Method for simultaneously measuring 31 stimulant substances in complex matrix cosmetics | 国家体育总局反兴奋剂中心(中国反兴奋剂中心) | 2026-05-19 | — | — | CN | claimed |
| CN-119165068-A | Construction of lymphoma early diagnosis model based on peripheral blood metabonomics by utilizing neural network and application | 中国医科大学附属盛京医院 | 2024-12-20 | — | — | CN | claimed |
| CN-118108782-A | Preparation method of mesotrione intermediate | 潘高峰 | 2024-05-31 | — | — | CN | claimed |
| CN-110618225-B | Method for constructing database to detect hormone | 吉林出入境检验检疫局检验检疫技术中心 | 2021-11-26 | — | — | CN | claimed |
| CN-108796021-B | Engineering bacterium and application thereof in preparing testosterone | 沈阳博泰生物制药有限公司 | 2021-03-19 | — | — | CN | claimed |
| CN-110618225-A | Method for constructing database to detect hormone | 吉林出入境检验检疫局检验检疫技术中心 | 2019-12-27 | — | — | CN | claimed |
| US-9827407-B2 | Applicator system for applying a viscous liquid to the human skin | FERRING B.V. (NL) | 2017-11-28 | — | — | US | claimed |
| US-9616072-B2 | Reduction of side effects from aromatase inhibitors used for treating breast cancer | CHAVAH PTY LTD. (AU) | 2017-04-11 | — | — | US | claimed |
| US-9452174-B2 | Oral transmucosal pharmaceutical compositions including testosterone and a C-SERM | PROFESSIONAL COMPOUNDING CENTERS OF AMERICA (US) | 2016-09-27 | — | — | US | claimed |
| US-20160129015-A1 | Reduction of Side Effects from Aromatase Inhibitors Used for Treating Breast Cancer | Havah Therapeutics Pty Ltd. (AU) | 2016-05-12 | — | — | US | claimed |
| US-20030062042-A1 | Aerosol generating method and device | ALEXZA PHARMACEUTICALS, INC. | 2003-04-03 | — | — | US | claimed |
| US-20030051728-A1 | Method and device for delivering a physiologically active compound | ALEXZA PHARMACEUTICALS, INC. | 2003-03-20 | — | — | US | claimed |
| EP-0981327-B1 | INTRAVAGINAL DRUG DELIVERY DEVICES FOR THE ADMINISTRATION OF TESTOSTERONE AND TESTOSTERONE PRECURSORS | GALEN CHEMICALS LTD (IE) | 2002-11-06 | — | — | EP | claimed |
| US-6469016-B1 | VAGINAL, VULVAR AND/OR URETHRAL ADMINISTRATION OF A PHARMACEUTICAL FORMULATION CONTAINING A VASOACTIVE AGENT TO INCREASE VAGINAL LUBRICATION | VIVUS, INC. | 2002-10-22 | — | — | US | claimed |
| CN-1367698-A | Administration of non-oral androgenic steroids to women | WATSON PHARMACEUTICALS INC (US) | 2002-09-04 | — | — | CN | claimed |
| US-6416780-B1 | Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors | GALEN (CHEMICALS) LIMITED (IE) | 2002-07-09 | — | — | US | claimed |
| EP-1189619-A1 | ADMINISTRATION OF NON-ORAL ANDROGENIC STEROIDS TO WOMEN | Watson Pharmaceuticals, Inc. (US) | 2002-03-27 | — | — | EP | claimed |
| WO-2000076522-A1 | ADMINISTRATION OF NON-ORAL ANDROGENIC STEROIDS TO WOMEN | WATSON PHARMACEUTICALS, INC. (US) | 2000-12-21 | — | — | WO | claimed |
| US-6099864-A | In situ activation of microcapsules | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF THE NATIONAL AERONAUTICS AND SPACE ADMINISTRATION (US) | 2000-08-08 | — | — | US | claimed |
| WO-1999059554-A1 | IN SITU ACTIVATION OF MICROCAPSULES | NASA/JOHNSON SPACE CENTER (US) | 1999-11-25 | — | — | WO | claimed |